These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD. Corey KE; Pitts R; Lai M; Loureiro J; Masia R; Osganian SA; Gustafson JL; Hutter MM; Gee DW; Meireles OR; Witkowski ER; Richards SM; Jacob J; Finkel N; Ngo D; Wang TJ; Gerszten RE; Ukomadu C; Jennings LL J Hepatol; 2022 Jan; 76(1):25-33. PubMed ID: 34600973 [TBL] [Abstract][Full Text] [Related]
6. Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis. Zhu Q; Li H; Ao Z; Xu H; Luo J; Kaurich C; Yang R; Zhu PW; Chen SD; Wang XD; Tang LJ; Li G; Huang OY; Zheng MH; Li HP; Liu F J Nanobiotechnology; 2022 Jul; 20(1):349. PubMed ID: 35897102 [TBL] [Abstract][Full Text] [Related]
7. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers. Vilar-Gomez E; Chalasani N J Hepatol; 2018 Feb; 68(2):305-315. PubMed ID: 29154965 [TBL] [Abstract][Full Text] [Related]
8. Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes. Bayliss J; Ooi GJ; De Nardo W; Shah YJH; Montgomery MK; McLean C; Kemp W; Roberts SK; Brown WA; Burton PR; Watt MJ Front Endocrinol (Lausanne); 2021; 12():642432. PubMed ID: 33746906 [TBL] [Abstract][Full Text] [Related]
9. NIS2+™, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: A prospective derivation and validation study. Harrison SA; Ratziu V; Magnanensi J; Hajji Y; Deledicque S; Majd Z; Rosenquist C; Hum DW; Staels B; Anstee QM; Sanyal AJ J Hepatol; 2023 Sep; 79(3):758-767. PubMed ID: 37224923 [TBL] [Abstract][Full Text] [Related]
10. Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis. Du SX; Lu LL; Geng N; Victor DW; Chen LZ; Wang C; Yue HY; Xin YN; Xuan SY; Jin WW Lipids Health Dis; 2017 Dec; 16(1):228. PubMed ID: 29197393 [TBL] [Abstract][Full Text] [Related]
11. Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics. Sydor S; Dandyk C; Schwerdt J; Manka P; Benndorf D; Lehmann T; Schallert K; Wolf M; Reichl U; Canbay A; Bechmann LP; Heyer R Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012106 [TBL] [Abstract][Full Text] [Related]
12. S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis. Liu X; Wang Y; Ming Y; Song Y; Zhang J; Chen X; Zeng M; Mao Y PLoS One; 2015; 10(5):e0127352. PubMed ID: 25993652 [TBL] [Abstract][Full Text] [Related]
13. ASC, IL-18 and Galectin-3 as Biomarkers of Non-Alcoholic Steatohepatitis: A Proof of Concept Study. Cyr B; Keane RW; de Rivero Vaccari JP Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33203036 [TBL] [Abstract][Full Text] [Related]
14. Serum C16:1n7/C16:0 ratio as a diagnostic marker for non-alcoholic steatohepatitis. Yamada K; Mizukoshi E; Seike T; Horii R; Terashima T; Iida N; Kitahara M; Sunagozaka H; Arai K; Yamashita T; Honda M; Takamura T; Harada K; Kaneko S J Gastroenterol Hepatol; 2019 Oct; 34(10):1829-1835. PubMed ID: 30864239 [TBL] [Abstract][Full Text] [Related]
15. Application of Machine Learning Methods to Predict Non-Alcoholic Steatohepatitis (NASH) in Non-Alcoholic Fatty Liver (NAFL) Patients. Fialoke S; Malarstig A; Miller MR; Dumitriu A AMIA Annu Symp Proc; 2018; 2018():430-439. PubMed ID: 30815083 [TBL] [Abstract][Full Text] [Related]
16. Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis. Xu G; Wang YM; Ying MM; Chen SD; Li ZR; Ma HL; Zheng MH; Wu J; Ding C Clin Mol Hepatol; 2021 Apr; 27(2):329-345. PubMed ID: 33465844 [TBL] [Abstract][Full Text] [Related]
17. Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis. Yang M; Xu D; Liu Y; Guo X; Li W; Guo C; Zhang H; Gao Y; Mao Y; Zhao J PLoS One; 2015; 10(6):e0131664. PubMed ID: 26121037 [TBL] [Abstract][Full Text] [Related]
18. miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. Liu CH; Ampuero J; Gil-Gómez A; Montero-Vallejo R; Rojas Á; Muñoz-Hernández R; Gallego-Durán R; Romero-Gómez M J Hepatol; 2018 Dec; 69(6):1335-1348. PubMed ID: 30142428 [TBL] [Abstract][Full Text] [Related]